Royal Bank Of Canada Revance Therapeutics, Inc. Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 29,597 shares of RVNC stock, worth $76,064. This represents 0.0% of its overall portfolio holdings.

Number of Shares

29,597

Previous 29,107 1.68%

Holding current value

$76,064

Previous $74,000 2.7%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	N/A	490 Added 1.68%	29,597 $76,000
Q3 2024 Nov 14, 2024	BUY	$2.57 - $2.57 $1,709 - $1,709	665 Added 2.34%	29,107 $74,000
Q2 2024 Aug 14, 2024	SELL	$2.34 - $4.73 $155,167 - $313,651	-66,311 Reduced 69.98%	28,442 $73,000
Q1 2024 Nov 05, 2024	BUY	$4.65 - $9.31 $308,346 - $617,355	66,311 Added 233.14%	94,753 $466,000
Q1 2024 May 15, 2024	BUY	$4.65 - $9.31 $25,226 - $50,506	5,425 Added 6.07%	94,753 $466,000
Q4 2023 Feb 14, 2024	BUY	$5.81 - $11.2 $99,147 - $191,128	17,065 Added 23.62%	89,328 $785,000
Q3 2023 Nov 14, 2023	BUY	$11.47 - $25.07 $338,972 - $740,893	29,553 Added 69.19%	72,263 $828,000
Q2 2023 Aug 14, 2023	SELL	$24.7 - $37.61 $27,244 - $41,483	-1,103 Reduced 2.52%	42,710 $1.08 Million
Q1 2023 May 15, 2023	SELL	$18.36 - $35.27 $364,978 - $701,132	-19,879 Reduced 31.21%	43,813 $1.41 Million
Q4 2022 Feb 14, 2023	BUY	$18.32 - $30.66 $207,382 - $347,071	11,320 Added 21.61%	63,692 $1.18 Million
Q3 2022 Nov 14, 2022	SELL	$14.33 - $28.47 $301,861 - $599,720	-21,065 Reduced 28.68%	52,372 $1.41 Million
Q2 2022 Aug 15, 2022	BUY	$11.52 - $20.4 $195,528 - $346,249	16,973 Added 30.06%	73,437 $1.01 Million
Q1 2022 May 16, 2022	SELL	$12.36 - $20.31 $4,956 - $8,144	-401 Reduced 0.71%	56,464 $1.1 Million
Q4 2021 Feb 14, 2022	BUY	$12.46 - $27.87 $190,401 - $425,881	15,281 Added 36.75%	56,865 $928,000
Q3 2021 Nov 15, 2021	BUY	$25.78 - $33.21 $437,512 - $563,606	16,971 Added 68.95%	41,584 $1.16 Million
Q2 2021 Aug 16, 2021	BUY	$26.8 - $31.84 $659,628 - $783,677	24,613 New	24,613 $730,000

Others Institutions Holding RVNC

# of Institutions

208

Shares Held

80.9M

Call Options Held

2.26M

Put Options Held

5.48M

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Revance Therapeutics, Inc. Transaction History